Evaluating Access to Prescription Medications in the Atopic Dermatitis Patient Population in the USA.

Allison R LoiselleRaj ChovatiyaIsabelle J ThibauJessica K JohnsonMichele GuadalupeWendy Smith Begolka

Published in: Dermatology and therapy (2024)

Patients with AD frequently experience insurance-related barriers to obtaining recommended therapies, and many do not know how to respond when these barriers arise. Strategies to improve timely therapeutic access are needed.

Keyphrases

atopic dermatitis
case report
health insurance
healthcare
long term care
drug induced